Both integrated and differential regulation of components of the IL-2/IL-2 receptor system

Cytokine and Growth Factor Reviews

Volumn 17, Issue 5, 2006, Pages 349-366

  Kim, Hyoung Pyo ^a   Imbert, Jean ^b   Leonard, Warren J ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b AIX MARSEILLE UNIVERSITY   (France)

Author keywords

c; IL 2; IL 2 receptor; Transcription; XSCID

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; EARLY GROWTH RESPONSE FACTOR 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 2 RECEPTOR BETA; OCTAMER TRANSCRIPTION FACTOR 1; OCTAMER TRANSCRIPTION FACTOR 2; RECOMBINANT INTERLEUKIN 2; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR NFAT; TRANSCRIPTION FACTOR SP1;

CANCER IMMUNOTHERAPY; CHROMATIN ASSEMBLY AND DISASSEMBLY; COMBINED IMMUNODEFICIENCY; CYTOKINE PRODUCTION; EPIGENETICS; FUNCTIONAL PROTEOMICS; GENE FREQUENCY; GENE LOCUS; GENETIC REGULATION; HUMAN; IMMUNOGENETICS; IMMUNOPHENOTYPING; IMMUNOREGULATION; KIDNEY CARCINOMA; KNOCKOUT MOUSE; MELANOMA; MEMORY CELL; NONHODGKIN LYMPHOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MODIFICATION; PROTEIN STRUCTURE; RECEPTOR INTRINSIC ACTIVITY; REGULATOR GENE; REGULATORY T LYMPHOCYTE; REVIEW; THYMOCYTE; TRANSCRIPTION REGULATION;

ANIMALS; CYCLIC AMP RESPONSE ELEMENT MODULATOR; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-2; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; INTERLEUKIN-2 RECEPTOR BETA SUBUNIT; MICE; NF-KAPPA B; NFATC TRANSCRIPTION FACTORS; PHENOTYPE; RECEPTORS, INTERLEUKIN-2; RNA PROCESSING, POST-TRANSCRIPTIONAL; STAT5 TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP-1;

EID: 33750219508     PISSN: 13596101     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cytogfr.2006.07.003     Document Type: Review

References (160)

1. Morgan D.A., Ruscetti F.W., and Gallo R. Selective in vitro growth of T lymphocytes from normal human bone marrows. Science 193 (1976) 1007-1008
2. Taniguchi T., Matsui H., Fujita T., et al. Structure and expression of a cloned cDNA for human interleukin-2. Nature 302 (1983) 305-310
3. Leonard W.J., Depper J.M., Crabtree G.R., et al. Molecular cloning and expression of cDNAs for the human interleukin-2 receptor. Nature 311 (1984) 626-631
4. Nikaido T., Shimizu A., Ishida N., et al. Molecular cloning of cDNA encoding human interleukin-2 receptor. Nature 311 (1984) 631-635
5. Green D.R., Droin N., and Pinkoski M. Activation-induced cell death in T cells. Immunol Rev 193 (2003) 70-81
6. Malek T.R., and Bayer A.L. Tolerance, not immunity, crucially depends on IL-2. Nat Rev Immunol 4 (2004) 665-674
7. Rosenberg S.A. Progress in human tumour immunology and immunotherapy. Nature 411 (2001) 380-384
8. Paredes R., Lopez Benaldo de Quiros J.C., Fernandez-Cruz E., Clotet B., and Lane H.C. The potential role of interleukin-2 in patients with HIV infection. AIDS Rev 4 (2002) 36-40
9. Leonard W.J., Depper J.M., Uchiyama T., Smith K.A., Waldmann T.A., and Greene W.C. A monoclonal antibody that appears to recognize the receptor for human T-cell growth factor; partial characterization of the receptor. Nature 300 (1982) 267-269
10. Sharon M., Klausner R.D., Cullen B.R., Chizzonite R., and Leonard W.J. Novel interleukin-2 receptor subunit detected by cross-linking under high-affinity conditions. Science 234 (1986) 859-863
11. Tsudo M., Kozak R.W., Goldman C.K., and Waldmann T.A. Demonstration of a non-Tac peptide that binds interleukin 2: a potential participant in a multichain interleukin 2 receptor complex. Proc Natl Acad Sci USA 83 (1986) 9694-9698
12. Hatakeyama M., Tsudo M., Minamoto S., et al. Interleukin-2 receptor beta chain gene: generation of three receptor forms by cloned human alpha and beta chain cDNA's. Science 244 (1989) 551-556
13. Takeshita T., Asao H., Ohtani K., et al. Cloning of the gamma chain of the human IL-2 receptor. Science 257 (1992) 379-382
14. Noguchi M., Nakamura Y., Russell S.M., et al. Interleukin-2 receptor gamma chain: a functional component of the interleukin-7 receptor. Science 262 (1993) 1877-1880 [See comments]
15. Leonard W.J. The molecular basis of X-linked severe combined immunodeficiency: defective cytokine receptor signaling. Annu Rev Med 47 (1996) 229-239
16. Taniguchi T. Cytokine signaling through nonreceptor protein tyrosine kinases. Science 268 (1995) 251-255
17. Robb R.J., Rusk C.M., Yodoi J., and Greene W.C. Interleukin 2 binding molecule distinct from the Tac protein: analysis of its role in formation of high-affinity receptors. Proc Natl Acad Sci USA 84 (1987) 2002-2006
18. Nakamura Y., Russell S.M., Mess S.A., et al. Heterodimerization of the IL-2 receptor beta- and gamma-chain cytoplasmic domains is required for signalling. Nature 369 (1994) 330-333
19. Nelson B.H., Lord J.D., and Greenberg P.D. Cytoplasmic domains of the interleukin-2 receptor beta and gamma chains mediate the signal for T-cell proliferation. Nature 369 (1994) 333-336
20. Leonard W.J. Type I cytokines and interferons and their receptors (2003), Lippincott Williams & Wilkins, Philadelphia, PA
21. c receptors. Science 310 (2005) 1159-1163
22. Stauber D.J., Debler E.W., Horton P.A., Smith K.A., and Wilson I.A. Crystal structure of the IL-2 signaling complex: paradigm for a heterotrimeric cytokine receptor. Proc Natl Acad Sci USA 103 (2006) 2788-2793
23. Sadlack B., Merz H., Schorle H., Schimpl A., Feller A.C., and Horak I. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 75 (1993) 253-261
24. Schorle H., Holtschke T., Hunig T., Schimpl A., and Horak I. Development and function of T cells in mice rendered interleukin-2 deficient by gene targeting. Nature 352 (1991) 621-624
25. Willerford D.M., Chen J., Ferry J.A., Davidson L., Ma A., and Alt F.W. Interleukin-2 receptor alpha chain regulates the size and content of the peripheral lymphoid compartment. Immunity 3 (1995) 521-530
26. Sharfe N., Dadi H.K., Shahar M., and Roifman C.M. Human immune disorder arising from mutation of the alpha chain of the interleukin-2 receptor. Proc Natl Acad Sci USA 94 (1997) 3168-3171
27. Suzuki H., Kundig T.M., Furlonger C., et al. Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor beta. Science 268 (1995) 1472-1476
28. Suzuki H., Duncan G.S., Takimoto H., and Mak T.W. Abnormal development of intestinal intraepithelial lymphocytes and peripheral natural killer cells in mice lacking the IL-2 receptor beta chain. J Exp Med 185 (1997) 499-505
29. Malek T.R., Yu A., Vincek V., Scibelli P., and Kong L.S. CD4 regulatory T cells prevent lethal autoimmunity in IL-2Rbeta-deficient mice. Implications for the nonredundant function of IL-2. Immunity 17 (2002) 167-178
30. Gilmour K.C., Fujii H., Cranston T., Davies E.G., Kinnon C., and Gaspar H.B. Defective expression of the interleukin-2/interleukin-15 receptor beta subunit leads to a natural killer cell-deficient form of severe combined immunodeficiency. Blood 98 (2001) 877-879
31. Cao X., Shores E.W., Hu-Li J., et al. Defective lymphoid development in mice lacking expression of the common cytokine receptor gamma chain. Immunity 2 (1995) 223-238
32. DiSanto J.P., Muller W., Guy-Grand D., Fischer A., and Rajewsky K. Lymphoid development in mice with a targeted deletion of the interleukin 2 receptor gamma chain. Proc Natl Acad Sci USA 92 (1995) 377-381
33. Nakajima H., Shores E.W., Noguchi M., and Leonard W.J. The common cytokine receptor gamma chain plays an essential role in regulating lymphoid homeostasis. J Exp Med 185 (1997) 189-195
34. Leonard W.J. Cytokines and immunodeficiency diseases. Nat Rev Immunol 1 (2001) 200-208
35. Buckley R.H. Molecular defects in human severe combined immunodeficiency and approaches to immune reconstitution. Annu Rev Immunol 22 (2004) 625-655
36. Granucci F., Zanoni I., Feau S., and Ricciardi-Castagnoli P. Dendritic cell regulation of immune responses: a new role for interleukin 2 at the intersection of innate and adaptive immunity. EMBO J 22 (2003) 2546-2551
37. Rothenberg E.V., and Ward S.B. A dynamic assembly of diverse transcription factors integrates activation and cell-type information for interleukin 2 gene regulation. Proc Natl Acad Sci USA 93 (1996) 9358-9365
38. Rooney J.W., Sun Y.L., Glimcher L.H., and Hoey T. Novel NFAT sites that mediate activation of the interleukin-2 promoter in response to T-cell receptor stimulation. Mol Cell Biol 15 (1995) 6299-6310
39. Yoshida H., Nishina H., Takimoto H., et al. The transcription factor NF-ATcl regulates lymphocyte proliferation and Th2 cytokine production. Immunity 8 (1998) 115-124
40. Hodge M.R., Ranger A.M., Charles de la Brousse F., Hoey T., Grusby M.J., and Glimcher L.H. Hyperproliferation and dysregulation of IL-4 expression in NF-ATp-deficient mice. Immunity 4 (1996) 397-405
41. Peng S.L., Gerth A.J., Ranger A.M., and Glimcher L.H.K. NFATc1 and NFATc2 together control both T and B cell activation and differentiation. Immunity 14 (2001) 13-20
42. Ranger A.M., Oukka M., Rengarajan J., and Glimcher L.H. Inhibitory function of two NFAT family members in lymphoid homeostasis and Th2 development. Immunity 9 (1998) 627-635
43. Shaulian E., and Karin M. AP-1 as a regulator of cell life and death. Nat Cell Biol 4 (2002) E131-E136
44. Dong C., Yang D.D., Wysk M., Whitmarsh A.J., Davis R.J., Flavell R.A., and Defective. T cell differentiation in the absence of Jnk1. Science 282 (1998) 2092-2095
45. + T cells to Thl cells requires MAP kinase JNK2. Immunity 9 (1998) 575-585
46. Conze D., Krahl T., Kennedy N., et al. c-Jun NH(2)-terminal kinase (JNK) 1 and JNK2 have distinct roles in CD8(+) T cell activation. J Exp Med 195 (2002) 811-823
47. Sabapathy K., Hu Y., Kallunki T., et al. JNK2 is required for efficient T-cell activation and apoptosis but not for normal lymphocyte development. Curr Biol 9 (1999) 116-125
48. Sabapathy K., Kallunki T., David J.P., Graef I., Karin M., and Wagner E.F. c-Jun NH2-terminal kinase (JNK) 1 and JNK2 have similar and stage-dependent roles in regulating T cell apoptosis and proliferation. J Exp Med 193 (2001) 317-328
49. Ghosh S., May M.J., and Kopp E.B. NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol 16 (1998) 225-260
50. Shapiro V.S., Truitt K.E., Imboden J.B., and Weiss A. CD28 mediates transcriptional upregulation of the interleukin-2 (IL-2) promoter through a composite element containing the CD28RE and NF-IL-2B AP-1 sites. Mol Cell Biol 17 (1997) 4051-4058
51. Himes S.R., Coles L.S., Reeves R., and Shannon M.F. High mobility group protein I(Y) is required for function and for c-Rel binding to CD28 response elements within the GM-CSF and IL-2 promoters. Immunity 5 (1996) 479-489
52. Doi T.S., Takahashi T., Taguchi O., Azuma T., and Obata Y. NF-kappa B RelA-deficient lymphocytes: normal development of T cells and B cells, impaired production of IgA and IgGl and reduced proliferative responses. J Exp Med 185 (1997) 953-961
53. Kontgen F., Grumont R.J., Strasser A., et al. Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression. Genes Dev 9 (1995) 1965-1977
54. Yang L., Cohn L., Zhang D.H., Homer R., Ray A., and Ray P. Essential role of nuclear factor kappaB in the induction of eosinophilia in allergic airway inflammation. J Exp Med 188 (1998) 1739-1750
55. + T lymphocytes. Science 256 (1992) 1452-1456
56. Jain J., Valge-Archer V.E., and Rao A. Analysis of the AP-1 sites in the IL-2 promoter. J Immunol 148 (1992) 1240-1250
57. Powell J.D., Lerner C.G., Ewoldt G.R., and Schwartz R.H. The -180 site of the IL-2 promoter is the target of CREB/CREM binding in T cell anergy. J Immunol 163 (1999) 6631-6639
58. De Cesare D., Fimia G.M., and Sassone-Corsi P. Signaling routes to CREM and CREB: plasticity in transcriptional activation. Trends Biochem Sci 24 (1999) 281-285
59. Tenbrock K., Juang Y.T., Gourley M.F., Nambiar M.P., and Tsokos G.C. Antisense cyclic adenosine 5′-monophosphate response element modulator up-regulates IL-2 in T cells from patients with systemic lupus erythematosus. J Immunol 169 (2002) 4147-4152
60. Tenbrock K., Juang Y.T., Tolnay M., and Tsokos G.C. The cyclic adenosine 5′-monophosphate response element modulator suppresses IL-2 production in stimulated T cells by a chromatin-dependent mechanism. J Immunol 170 (2003) 2971-2976
61. Barton K., Muthusamy N., Chanyangam M., Fischer C., Clendenin C., and Leiden J.M. Defective thymocyte proliferation and IL-2 production in transgenic mice expressing a dominant-negative form of CREB. Nature 379 (1996) 81-85
62. Ullman K.S., Flanagan W.M., Edwards C.A., and Crabtree G.R. Activation of early gene expression in T lymphocytes by Oct-1 and an inducible protein, OAP40. Science 254 (1991) 558-562
63. Pfeuffer I., Klein-Hessling S., Heinfling A., et al. Octamer factors exert a dual effect on the IL-2 and IL-4 promoters. J Immunol 153 (1994) 5572-5585
64. Briggs M.R., Kadonaga J.T., Bell S.P., and Tjian R. Purification and biochemical characterization of the promoter-specific transcription factor, Spl. Science 234 (1986) 47-52
65. Kriwacki R.W., Schultz S.C., Steitz T.A., and Caradonna J.P. Sequence-specific recognition of DNA by zinc-finger peptides derived from the transcription factor Spl. Proc Natl Acad Sci USA 89 (1992) 9759-9763
66. Chavrier P., Lemaire P., Revelant O., Bravo R., and Charnay P. Characterization of a mouse multigene family that encodes zinc finger structures. Mol Cell Biol 8 (1988) 1319-1326
67. Gashler A., and Sukhatme V.P. Early growth response protein 1 (Egr-1): prototype of a zinc-finger family of transcription factors. Prog Nucl Acid Res Mol Biol 50 (1995) 191-224
68. Skerka C., Decker E.L., and Zipfel P.F. A regulatory element in the human interleukin 2 gene promoter is a binding site for the zinc finger proteins Sp1 and EGR-1. J Biol Chem 270 (1995) 22500-22506
69. Decker E.L., Skerka C., and Zipfel P.F. The early growth response protein (EGR-1) regulates interleukin-2 transcription by synergistic interaction with the nuclear factor of activated T cells. J Biol Chem 273 (1998) 26923-26930
70. Batchelor A.H., Piper D.E., de la Brousse F.C., McKnight S.L., and Wolberger C. The structure of GABPa lpha/beta: an ETS domain-ankyrin repeat heterodimer bound to DNA. Science 279 (1998) 1037-1041
71. Avots A., Hoffmeyer A., Flory E., Cimanis A., Rapp U.R., and Serfling E. GABP factors bind to a distal interleukin 2 (IL-2) enhancer and contribute to c-Raf-mediated increase in IL-2 induction. Mol Cell Biol 17 (1997) 4381-4389
72. Hoffmeyer A., Avots A., Flory E., Weber C.K., Serfling E., and Rapp U.R. The GABP-responsive element of the interleukin-2 enhancer is regulated by JNK/SAPK-activating pathways in T lymphocytes. J Biol Chem 273 (1998) 10112-10119
73. Williams T.M., Moolten D., Burlein J., et al. Identification of a zinc finger protein that inhibits IL-2 gene expression. Science 254 (1991) 1791-1794
74. Becker J.C., Brabletz T., Kirchner T., Conrad C.T., Brocker E.B., and Reisfeld R.A. Negative transcriptional regulation in anergic T cells. Proc Natl Acad Sci USA 92 (1995) 2375-2378
75. Pucci S., Doria G., Barile S., Pioli C., and Frasca D. Inhibition of IL-2 production by Nil-2-a in murine T cells. Int Immunol 10 (1998) 1435-1440
76. Yasui D.H., Genetta T., Kadesch T., et al. Transcriptional repression of the IL-2 gene in Th cells by ZEB. J Immunol 160 (1998) 4433-4440
77. Alvarez J.D., Yasui D.H., Niida H., Joh T., Loh D.Y., and Kohwi-Shigematsu T.Y. The MAR-binding protein SATB1 orchestrates temporal and spatial expression of multiple genes during T-cell development. Genes Dev 14 (2000) 521-535
78. Yasui D., Miyano M., Cai S., Varga-Weisz P., and Kohwi-Shigematsu T. SATB1 targets chromatin remodelling to regulate genes over long distances. Nature 419 (2002) 641-645
79. Kumar P.P., Purbey P.K., Ravi D.S., Mitra D., and Galande S. Displacement of SATBl-bound histone deacetylase 1 corepressor by the human immunodeficiency virus type 1 transactivator induces expression of interleukin-2 and its receptor in T cells. Mol Cell Biol 25 (2005) 1620-1633
80. Schubert L.A., Jeffery E., Zhang Y., Ramsdell F., and Ziegler S.F. Scurfin (FOXP3) acts as a repressor of transcription and regulates T cell activation. J Biol Chem 276 (2001) 37672-37679
81. Bettelli E., Dastrange M., and Oukka M. Foxp3 interacts with nuclear factor of activated T cells and NF-kappa B to repress cytokine gene expression and effector functions of T helper cells. Proc Natl Acad Sci USA 102 (2005) 5138-5143
82. Bruniquel D., and Schwartz R.H. Selective, stable demethylation of the interleukin-2 gene enhances transcription by an active process. Nat Immunol 4 (2003) 235-240
83. Durand D.B., Shaw J.P., Bush M.R., Replogle R.E., Belagaje R., and Crabtree G.R. Characterization of antigen receptor response elements within the interleukin-2 enhancer. Mol Cell Biol 8 (1988) 1715-1724
84. Murayama A., Sakura K., Nakama M., et al. A specific CpG site demethylation in the human interleukin 2 gene promoter is an epigenetic memory. EMBO J 25 (2006) 1081-1092
85. Ward S.B., Hernandez-Hoyos G., Chen F., Waterman M., Reeves R., and Rothenberg E.V. Chromatin remodeling of the interleukin-2 gene: distinct alterations in the proximal versus distal enhancer regions. Nucl Acids Res 26 (1998) 2923-2934
86. Attema J.L., Reeves R., Murray V., et al. The human IL-2 gene promoter can assemble a positioned nucleosome that becomes remodeled upon T cell activation. J Immunol 169 (2002) 2466-2476
87. Thomas R.M., Gao L., and Wells A.D. Signals from CD28 induce stable epigenetic modification of the IL-2 promoter. J Immunol 174 (2005) 4639-4646
88. + T cells in vivo is rapid, transient, and influenced by TCR-specific competition. J Immunol 172 (2004) 6136-6143
89. Hollander G.A., Zuklys S., Morel C., et al. Monoallelic expression of the interleukin-2 locus. Science 279 (1998) 2118-2121
90. Naramura M., Hu R.J., and Gu H. Mice with a fluorescent marker for interleukin 2 gene activation. Immunity 9 (1998) 209-216
91. Chiodetti L., Barber D.L., and Schwartz R.H. Biallelic expression of the IL-2 locus under optimal stimulation conditions. Eur J Immunol 30 (2000) 2157-2163
92. Brombacher F., Schafer T., Weissenstein U., et al. IL-2 promoter-driven lacZ expression as a monitoring tool for IL-2 expression in primary T cells of transgenic mice. Int Immunol 6 (1994) 189-197
93. Yui M.A., Hernandez-Hoyos G., and Rothenberg E.V. A new regulatory region of the IL-2 locus that confers position-independent transgene expression. J Immunol 166 (2001) 1730-1739
94. Lindstein T., June C.H., Ledbetter J.A., Stella G., and Thompson C.B. Regulation of lymphokine messenger RNA stability by a surface-mediated T cell activation pathway. Science 244 (1989) 339-343
95. Chen C.Y., Del Gatto-Konczak F., Wu Z., and Karin M. Stabilization of interleukin-2 mRNA by the c-Jun NH2-terminal kinase pathway. Science 280 (1998) 1945-1949
96. Chen C.Y., Gherzi R., Andersen J.S., et al. Nucleolin and YB-1 are required for JNK-mediated interleukin-2 mRNA stabilization during T-cell activation. Genes Dev 14 (2000) 1236-1248
97. Ragheb J.A., Deen M., and Schwartz R.H. CD28-mediated regulation of mRNA stability requires sequences within the coding region of the IL-2 mRNA. J Immunol 163 (1999) 120-129
98. Ragheb J.A., Deen M., and Schwartz R.H. The destabilization of IL-2 mRNA by a premature stop codon and its differential stabilization by trans-acting inhibitors of protein synthesis do not support a role for active translation in mRNA stability. J Immunol 163 (1999) 3321-3330
99. Jenkins M.K., Taylor P.S., Norton S.D., and Urdahl K.B. CD28 delivers a costimulatory signal involved in antigen-specific IL-2 production by human T cells. J Immunol 147 (1991) 2461-2466
100. Shahinian A., Pfeffer K., Lee K.P., et al. Differential T cell costimulatory requirements in CD28-deficient mice. Science 261 (1993) 609-612
101. Matikainen S., Sareneva T., Ronni T., Lehtonen A., Koskinen P.J., and Julkunen I. Interferon-alpha activates multiple STAT proteins and upregulates proliferation-associated IL-2Ralpha, c-myc, and pim-1 genes in human T cells. Blood 93 (1999) 1980-1991
102. + T cells by IL-16 and IL-2. J Immunol 160 (1998) 2115-2120
103. Waldmann T.A. The multi-subunit interleukin-2 receptor. Annu Rev Biochem 58 (1989) 875-911
104. Lin J.X., and Leonard W.J. Signaling from the IL-2 receptor to the nucleus. Cytokine Growth Factor Rev 8 (1997) 313-332
105. c (2003), Kluwer Academic Publishers, The Netherlands
106. Demaison C., Fiette L., Blanchetiere V., Schimpl A., Theze J., and Froussard P. IL-2 receptor alpha-chain expression is independently regulated in primary and secondary lymphoid organs. J Immunol 161 (1998) 1977-1982
107. Yeh J.H., Lecine P., Nunes J.A., et al. Novel CD28-responsive enhancer activated by CREB/ATF and AP-1 families in the human interleukin-2 receptor alpha-chain locus. Mol Cell Biol 21 (2001) 4515-4527
108. Smith M.R., and Greene W.C. The same 50-kDa cellular protein binds to the negative regulatory elements of the interleukin 2 receptor alpha-chain gene and the human immunodeficiency virus type 1 long terminal repeat. Proc Natl Acad Sci USA 86 (1989) 8526-8530
109. Lu Y., Sheng D.Q., Mo Z.C., Li H.F., Wu N.H., and Shen Y.F. A negative regulatory element-dependent inhibitory role of ITF2B on IL-2 receptor alpha gene. Biochem Biophys Res Commun 336 (2005) 142-149
110. Bohnlein E., Lowenthal J.W., Siekevitz M., Ballard D.W., Franza B.R., and Greene W.C. The same inducible nuclear proteins regulates mitogen activation of both the interleukin-2 receptor-alpha gene and type 1 HIV. Cell 53 (1988) 827-836
111. Cross S.L., Feinberg M.B., Wolf J.B., Holbrook N.J., Wong-Staal F., and Leonard W.J. Regulation of the human interleukin-2 receptor alpha chain promoter: activation of a nonfunctional promoter by the transactivator gene of HTLV-I. Cell 49 (1987) 47-56
112. Cross S.L., Halden N.F., Lenardo M.J., and Leonard W.J. Functionally distinct NF-kappa B binding sites in the immunoglobulin kappa and IL-2 receptor alpha chain genes. Science 244 (1989) 466-469
113. Lin B.B., Cross S.L., Halden N.F., Roman D.G., Toledano M.B., and Leonard W.J. Delineation of an enhancer like positive regulatory element in the interleukin-2 receptor alpha-chain gene. Mol Cell Biol 10 (1990) 850-853
114. Roman D.G., Toledano M.B., and Leonard W.J. Sp1 represses IL-2 receptor alpha chain gene expression. New Biol 2 (1990) 642-647
115. Kahn-Perles B., Lipcey C., Lecine P., Olive D., and Imbert J. Temporal and subunit-specific modulations of the Rel/NF-kappaB transcription factors through CD28 costimulation. J Biol Chem 272 (1997) 21774-21783
116. Pimentel-Muinos F.X., Mazana J., and Fresno M. Regulation of interleukin-2 receptor alpha chain expression and nuclear factor.kappa B activation by protein kinase C in T lymphocytes. Autocrine role of tumor necrosis factor alpha. J Biol Chem 269 (1994) 24424-24429
117. Algarte M., Lecine P., Costello R., Plet A., Olive D., and Imbert J. In vivo regulation of interleukin-2 receptor alpha gene transcription by the coordinated binding of constitutive and inducible factors in human primary T cells. EMBO J 14 (1995) 5060-5072
118. Yeh J.H., Spicuglia S., Kumar S., Sanchez-Sevilla A., Ferrier P., and Imbert J. Control of IL-2Ralpha gene expression: structural changes within the proximal enhancer/core promoter during T-cell development. Nucl Acids Res 30 (2002) 1944-1951
119. Gerondakis S., Strasser A., Metcalf D., Grigoriadis G., Scheerlinck J.Y., and Grumont R.J. Rel-deficient T cells exhibit defects in production of interleukin 3 and granulocyte-macrophage colony-stimulating factor. Proc Natl Acad Sci USA 93 (1996) 3405-3409
120. John S., Reeves R.B., Lin J.X., et al. Regulation of cell-type-specific interleukin-2 receptor alpha-chain gene expression: potential role of physical interactions between Elf-1, HMG-I(Y), and NF-kappa B family proteins. Mol Cell Biol 15 (1995) 1786-1796
121. Reeves R., Leonard W.J., and Nissen M.S. Binding of HMG-I(Y) imparts architectural specificity to a positioned nucleosome on the promoter of the human interleukin-2 receptor alpha gene. Mol Cell Biol 20 (2000) 4666-4679
122. Schuh K., Twardzik T., Kneitz B., Heyer J., Schimpl A., and Serfling E. The interleukin 2 receptor alpha chain/CD25 promoter is a target for nuclear factor of activated T cells. J Exp Med 188 (1998) 1369-1373
123. Kim H.P., and Leonard W.J. The basis for TCR-mediated regulation of the IL-2 receptor alpha chain gene: role of widely separated regulatory elements. EMBO J 21 (2002) 3051-3059
124. Rao A., Luo C., and Hogan P.G. Transcription factors of the NFAT family: regulation and function. Annu Rev Immunol 15 (1997) 707-747
125. Kim H.P., Korn L.L., Gamero A.M., and Leonard W.J. Calcium-dependent activation of interleukin-21 gene expression in T cells. J Biol Chem 280 (2005) 25291-25297
126. Hsueh Y.P., Liang H.E., Ng S.Y., and Lai M.Z. CD28-costimulation activates cyclic AMP-responsive element-binding protein in T lymphocytes. J Immunol 158 (1997) 85-93
127. Hughes-Fulford M., Sugano E., Schopper T., Li C.F., Boonyaratanakornkit J.B., and Cogoli A. Early immune response and regulation of IL-2 receptor subunits. Cell Signal 17 111 (2005) 1-1124
128. Horvath C.M., and Darnell J.E. The state of the STATs: recent developments in the study of signal transduction to the nucleus. Curr Opin Cell Biol 9 (1997) 233-239
129. Rusterholz C., Henrioud P.C., and Nabholz M. Interleukin-2 (IL-2) regulates the accessibility of the IL-2-responsive enhancer in the IL-2 receptor alpha gene to transcription factors. Mol Cell Biol 19 (1999) 2681-2689
130. Kim H.P., Kelly J., and Leonard W.J. The basis for IL-2-induced IL-2 receptor alpha chain gene regulation: importance of two widely separated IL-2 response elements. Immunity 15 (2001) 159-172
131. John S., Robbins C.M., and Leonard W.J. An IL-2 response element in the human IL-2 receptor alpha chain promoter is a composite element that binds Stat5, Elf-1. HMG-I(Y) and a GATA family protein. EMBO J 15 (1996) 5627-5635
132. Lecine P., Algarte M., Rameil P., et al. Elf-1 and Stat5 bind to a critical element in a new enhancer of the human interleukin-2 receptor alpha gene. Mol Cell Biol 16 (1996) 6829-6840
133. Serdobova I., Pla M., Reichenbach P., et al. Elf-1 contributes to the function of the complex interleukin (IL)-2-responsive enhancer in the mouse IL-2 receptor alpha gene. J Exp Med 185 (1997) 1211-1221
134. John S., Vinkemeier U., Soldaini E., Darnell Jr. J.E., and Leonard W.J. The significance of tetramerization in promoter recruitment by Stat5. Mol Cell Biol 19 (1999) 1910-1918
135. Rameil P., Lecine P., Ghysdael J., Gouilleux F., Kahn-Perles B., and Imbert J. IL-2 and long-term T cell activation induce physical and functional interaction between STAT5 and ETS transcription factors in human T cells. Oncogene 19 (2000) 2086-2097
136. Li M.O., Wan Y.Y., Sanjabi S., Robertson A.K., and Flavell R.A. Transforming growth factor-beta regulation of immune responses. Annu Rev Immunol (2005)
137. Kim H.P., Kim B.G., Letterio J., and Leonard W.J. Smad-dependent cooperative regulation of interleukin 2 receptor alpha chain gene expression by T cell receptor and transforming growth factor-beta. J Biol Chem 280 (2005) 34042-34047
138. + regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 198 (2003) 1875-1886
139. Lamas M., Campos J.R., and Silva A.G. Identification of a novel glucocorticoid response unit (GRU) in the 5′-flanking region of the mouse IL-2 receptor alpha gene. Cytokine 9 (1997) 973-981
140. Sidell N., Kummer U., Aframian D., and Thierfelder S. Retinoid regulation of interleukin-2 receptors on human T-cells. Cell Immunol 179 (1997) 116-125
141. Hewitt E.L., Ozanne B.W., and Cushley W. Negative regulation of the interleukin (IL)-2 receptor alpha chain (CD25) promoter region in human B lymphocytes. Cytokine 9 (1997) 982-991
142. Cerdan C., Martin Y., Courcoul M., et al. Prolonged IL-2 receptor alpha/CD25 expression after T cell activation via the adhesion molecules CD2 and CD28. Demonstration of combined transcriptional and post-transcriptional regulation. J Immunol 149 (1992) 2255-2261
143. Sharon M., Gnarra J.R., and Leonard W.J. A 100-kilodalton protein is associated with the murine interleukin 2 receptor: biochemical evidence that plOO is distinct from the alpha and beta chains. Proc Natl Acad Sci USA 87 (1990) 4869-4873
144. Siegel J.P., Sharon M., Smith P.L., and Leonard W.J. The IL-2 receptor beta chain (p70): role in mediating signals for LAK, NK, and proliferative activities. Science 238 (1987) 75-78
145. Tanaka T., Takeuchi Y., Shiohara T., et al. In utero treatment with monoclonal antibody to IL-2 receptor beta-chain completely abrogates development of Thy-1+ dendritic epidermal cells. Int Immunol 4 (1992) 487-491
146. Djeu J.Y., Liu J.H., Wei S., et al. Function associated with IL-2 receptor-beta on human neutrophils. Mechanism of activation of antifungal activity against Candida albicans by IL-2. J Immunol 150 (1993) 960-970
147. Cerdan C., Martin Y., Courcoul M., Mawas C., Birg F., and Olive D. CD28 costimulation up-regulates long-term IL-2R beta expression in human T cells through combined transcriptional and post-transcriptional regulation. J Immunol 154 (1995) 1007-1013
148. Lin J.X., Bhat N.K., John S., Queale W.S., and Leonard W.J. Characterization of the human interleukin-2 receptor beta-chain gene promoter: regulation of promoter activity by ets gene products. Mol Cell Biol 13 (1993) 6201-6210
149. Lin J.X., and Leonard W.J. The immediate-early gene product Egr-1 regulates the human interleukin-2 receptor beta-chain promoter through noncanonical Egr and Sp1 binding sites. Mol Cell Biol 17 (1997) 3714-3722
150. Casey L.S., Lichtman A.H., and Boothby M. IL-4 induces IL-2 receptor p75 beta-chain gene expression and IL-2-dependent proliferation in mouse T lymphocytes. J Immunol 148 (1992) 3418-3426
151. Wong J.C., Lee S.B., Bell M.D., et al. Induction of the interleukin-2/15 receptor beta-chain by the EWS-WT1 translocation product. Oncogene 21 (2002) 2009-2019
152. Ishii N., Takeshita T., Kimura Y., et al. Expression of the IL-2 receptor gamma chain on various populations in human peripheral blood. Int Immunol 6 (1994) 1273-1277
153. Kondo M., Ohashi Y., Tada K., Nakamura M., and Sugamura K. Expression of the mouse interleukin-2 receptor gamma chain in various cell populations of the thymus and spleen. Eur J Immunol 24 (1994) 2026-2030
154. Ohbo K., Takasawa N., Ishii N., Tanaka N., Nakamura M., and Sugamura K. Functional analysis of the human interleukin 2 receptor gamma chain gene promoter. J Biol Chem 270 (1995) 7479-7486
155. +T cell death. J Immunol 163 (1999) 3131-3137
156. c) by calpain. Proc Natl Acad Sci USA 94 (1997) 11534-11539
157. Bosco M.C., Espinoza-Delgado I., Schwabe M., et al. Regulation by interleukin-2 (IL-2) and interferon gamma of IL-2 receptor gamma chain gene expression in human monocytes. Blood 83 (1994) 2995-3002
158. Noguchi M., Adelstein S., Cao X., and Leonard W.J. Characterization of the human interleukin-2 receptor gamma chain gene. J Biol Chem 268 (1993) 13601-13608
159. Markiewicz S., Bosselut R., Le Deist F., et al. Tissue-specific activity of the gammac chain gene promoter depends upon an Ets binding site and is regulated by GA-binding protein. J Biol Chem 271 (1996) 14849-14855
160. Schwartz S., Zhang Z., Frazer K.A., et al. PipMaker-a web server for aligning two genomic DNA sequences. Genome Res 10 (2000) 577-586